Introduction
The HLA-B27 allele of MHC class I (B27) is a major risk factor for the development of human spondyloarthritis (SpA), however, its exact contribution to disease enhancement is poorly understood. Transgenic rats that express the human HLA-B27 and β 2 -microglobulin genes (B27 rats) develop multi-systemic inflammation that resembles the human SpA clinical spectrum (1, 2) . Inflammation in B27 rats starts in the intestine, with ileitis occurring before 10 weeks of age, followed by arthritis, psoriasis, and nail dystrophy (2) . A link between gut pathology and peripheral symptoms has been known for decades, as animals raised in germfree conditions develop neither colitis nor arthritis (3) . There has been renewed interest in the intestinal environment and its contribution to the development of B27-associated pathology.
It is now evident that the intestinal microbiome in B27 rats is profoundly different from that of healthy animals (4) . Importantly, the development of gut pathology in B27 rats is associated with specific strains of commensal bacteria (i.e., Bacteroides vulgatus), which can be manipulated by oral antibiotic treatment (5, 6) . The impact of microbial dysbiosis on the central and systemic immune system, and the subsequent effect of this on disease development is currently under investigation. Recent work in mice has shown that acute T.
gondii-driven intestinal inflammation can trigger changes in the bone marrow (BM) compartment, specifically BM monocyte precursor cells; fundamentally altering their function once they migrate into infected mucosal tissue (7) . Interestingly, B27 animals lack MHC class II + CD103 + CD172a low migrating dendritic cells, which are involved in controlling intestinal immune responses (8) . Furthermore, osteoclast pre-cursors in B27 rats have enhanced differentiation in response to TNFα compared to control animals, which contributes to the B27-associated bone loss (9) . It still remains to be determined, however, how changes in the myeloid compartment, and B27-associated microbial dysbiosis, affect the central and peripheral myeloid compartments, and the osteoclast they mature into.
Herein, we have characterised monocyte populations in B27 rats and investigated the effects of oral antibiotics on both intestinal pathology and the myeloid compartment. We have revealed close correlations between gut pathology and monocyte distribution and showed how the latter could directly contribute to B27-associated bone loss.
Materials and Methods

Animal studies.
Heterozygous B27 and B7 PVG rats were bred under license as previously described (3, 8) , maintained under specific pathogen-free conditions at the University of Glasgow, and used under licenses issued by the UK Home Office. All rats were used between 10-18 weeks of age.
In vivo antibiotic treatment.
Rats between 10-14 weeks of age were given 50mg/kg/day of Vancomycin and 2.5mg/kg/day of Ampicillin/Metranidazole/Neomycin re-suspended in filtered sterile drinking water.
Administration was by gavage daily on weekdays for 4 consecutive weeks (ABX treated group). Equal volume of sterile drinking water was given to control rats (CTRL). Blood was sampled twice a week from the tail vein and plasma stored. At day 26, animals were culled and blood, hind limbs and gut were harvested for downstream analysis.
Flow cytometry.
The white cell fraction of fresh isolated rat BM and blood was obtained by lysis of red cells using ACK lysing buffer (Life Technologies), and stained with fluorochrome-labelled antibodies and/or with biotinylated antibodies and fluorochrome-labelled streptavidin.
Briefly, Fcγ receptor was blocked using purified mouse anti-rat CD32 (D34-485; BD Biosciences) and cells were stained with biotinylated mouse anti-rat Ig κ, CD90 (OX-6), CD45RA (OX-33), and brilliant violet 605 TM (BV650) Streptavidin (BioLegend). Monocytes were identified using PE-CD172a (OX-41; BioLegend), APC-CD43 (W3/13; BioLegend), V450 or FITC-CD11b (WT.5; BD Biosciences). A DAPI solution (4',6-diamidino-2-phenylindole; Sigma-Aldrich) was used for live/dead cell exclusion. Cells were acquired using an LSRII analyser (BD Biosciences) and data analysed using FlowJo software (Tree Star).
Flow cytometry sorting of bone marrow cells.
Fluorescent-labelled cells were acquired and sorted using an Aria I sorter and a 70µm nozzle (BD Bioscience). Cells were sorted into tubes containing complete α-MEM media (supplemented with 10% FBS, 0,02 mM L-glutamine, 10 U/ml Penicillin, and 0.1 µg/ml Streptomycin; Invitrogen, Thermo Fisher Scientific) and kept a 4ºC till sorting completion.
Purity of post-sorting test showed purity ≥ 96%. Sorted cells were seeded in 96 well plates at 1x10 6 cells/ml and incubated overnight with 50 ng/ml M-CSF (PeproTech). On day 1, cells were stimulated with 50 ng/ml RANK-L (PeproTech). Medium was refreshed on day 4 and on day 6-7 cells were fixed and stained for tartrate-resistant acid phosphatase (TRAP) using the Acid Phosphatase TRAP kit, following the manufacturer's instructions (Sigma-Aldrich).
Four representative images were acquired per well at 10X magnification using an EVOS ® FL Auto Cell Imaging System (Life Technologies). Osteoclasts were identified as TRAP + (purple) cells with ≥3 nuclei and counted using Fiji software (Image J).
Uptake of fluorescent CCL2.
The fluorescent uptake of CCL2 toward CCR2 receptor was measured using Site-specific AF647® labelled chemokine purchased from ALMAC Group LTD, as previously described (10) . Briefly, fresh primary cells were incubated at 37°C for 1h with 25 nM CCL2 AF647
. Cells were then washed and stained for surface marker expression for flow cytometry.
Chemotaxis assay.
BM was collected from age-matched B7 and B27 rats. BM cells (BMCs) were suspended at 5x10 6 cells/ml in chemotaxis buffer (Dulbecco modified essential medium (DMEM) supplemented with 0.5% BSA; Life technology, Thermo Fisher Scientific) and 100 µl of the cell suspension was placed onto the top section of a bare filter trans-well (6.5 mm diameter) with 5 µm pore size (Corning, UK). Rat CCL2 (0, 10, 100 and 1000 ng/ml) was used as a chemo-attractant in the bottom section of the trans-wells (PeproTech). After 3 hours of incubation at 37ºC, trans-migration was assessed by counting the cells that had migrated into the bottom section of the well. Transmigrated cells were further collected and stained for flow cytometry.
Enzyme-linked immunosorbent assay (ELISA)
Blood was collected in heparinised tubes and plasma stored; rat CCL2 and IL-1α were measured by ELISA following the manufacturer's instructions (BioLegend and Thermo
Fisher Scientific respectively).
Rat bone marrow-derived monocyte collection and osteoclastogenesis.
Briefly, BM was flushed from long bones and red cells lysed with ACK lysing buffer (Life Technologies). BMCs were cultured at 1x10 6 cells/ml in α-MEM media (supplemented with 10% FBS, 0,02 mM L-glutamine, 10 U/ml Penicillin, and 0.1 µg/ml Streptomycin;
Invitrogen, Thermo Fisher Scientific) in the presence of 2.5 mM β-glycerophosphate and 0.05 mg/ml L-Ascorbic Acid (Sigma-Aldrich) for 2 days. After incubation, non-adherent BMCs (NA-BMCs) were collected, seeded at 2x10 5 cells/well in 96 well plates, and cultured in triplicate in the presence of 50 ng/ml M-CSF, 10 ng/ml RANK-L, and 50 ng/ml TNFα (PeproTech). Medium was refreshed on day 4 and on day 5 cells were fixed, stained for TRAP, and osteoclast quantified, as described above.
Rat gut: tissue processing, haematoxylin and eosin staining, and analysis
Several pieces of the ileum were collected from rats under terminal anaesthesia (4 atm Isoflourane and 4 atm O 2 ) and fixed in 4% neutral buffered formalin. Samples were dehydrated via increasing concentrations of ethanol and embedded in paraffin wax blocks.
Transversal and cross sections were cut at 5 µm using a microtome and stained for haematoxylin and eosin and mounted with DPX mountant (Sigma-Aldrich Chemical Co.).
Stained sections were imaged using an EVOS® FL Auto Cell Imaging System (Life Technologies) with a 10X objective. Villi and crypt length were measured using a Fiji software (ImageJ).
Statistical analysis
Prism 6 (Graphpad) was used to perform all statistical analysis and statistical tests used are indicated in the figure legends. For all statistical analysis, p-values of ≤0.05 were considered significant.
Results
B27 rats have an altered myeloid compartment with increased CD43 lo monocytes
Rat monocytes (M O s) within the blood and BM (11, 12) were identified as lin -(Igκ Interestingly, CD43 hi M O numbers were not significantly affected in B27 rats ( Figure 1C ).
This increased representation of CD43 lo M O s was also observed within the BM of B27 rats when compared to WT and B7 transgenic controls ( Figure 1D -F). Importantly, no differences were evident between WT and the B7 transgenic controls ( Figure 1 ).
Antibiotics reduce the number of circulating CD43 lo monocytes by restoring CCL2 plasma levels and reducing BM pre-cursor numbers.
Oral antibiotics are effective at attenuating signs of ileitis in B27 rats (6) . Using broadspectrum antibody treatment, we ameliorated B27-associated gut inflammation; as determined by reduced ileitis after 4 weeks of oral administration (Figure 2A-B) . Rat CD43 lo M O s express CCR2 (11), which is a key chemokine receptor involved in monocyte migration from the BM into the bloodstream and recruitment into inflamed tissues.
We confirmed CCR2 expression in CD43 lo M O s using fluorescently-labelled CCL2 ( Figure   3A ) and migration towards CCL2 ( Figure 3B ). Additionally, we observed significantly higher CCL2 plasma levels in B27 rats compared to controls ( Figure 3C ). These data indicate that there may be CCL2-dependent altered migration/recruitment of M O s in B27-associated diseases. This is supported by a significant positive correlation between CCL2 plasma levels and the number of circulating CD43 lo M O s in B27 rats ( Figure 3D ). Moreover, administration of antibiotics to B27 rats significantly decreased the plasma levels of CCL2 ( Figure 3E ).
Remarkably, one week after initiation of antibiotics, plasma CCL2 in B27 rats returned to levels similar to WT controls ( Figure 3E ). Furthermore, we evaluated whether or not the antibiotic treatment affected systemic cytokines in B27 rats. TNFα is known to be highly linked to B27-associated disease, however, it was undetectable in both plasma and serum (data not shown). In contrast, the level of IL-1α (a potent pro-inflammatory cytokine often associated with TNFα activity) was significantly higher in the plasma of B27 rats compared to controls ( Figure 3F ). Notably, IL-1α plasma levels in B27 rats substantially decreased following antibiotic treatment ( Figure 3G ). These data indicate that oral antibiotics not only reduces local inflammation in the gut but also have an impact on systemic inflammation by reducing circulating levels of IL-1α, CCL2, and CD43 lo M O s.
Oral antibiotic treatment re-establishes normal responsiveness to TNFα within the BM preosteoclast compartment of B27 rats
Recent studies have shown that murine monocyte sub-populations have different osteoclastogenic potential (13) . Evaluation of the osteoclastogenic potential of each of the rat BM monocyte populations revealed that the CD43 lo M O population contains the main osteoclast pre-cursors ( Figure 4) . Therefore, the observed increase in this population in B27 rats could contribute to the overt bone pathology observed in these animals as they age.
Furthermore, it has been demonstrated that BM pre-cursors from B27 rats undergo enhanced TNFα-driven (but not RANK-L) osteoclastogenesis compared to controls(9) (Supplemental Figure 2) . Moreover, the TNFα-enhancement of OC differentiation in B27 rats has been associated with IL-1α production and activity (9) , which is reduced in the plasma of B27 animals upon treatment with oral antibiotics ( Figure 3F ). Importantly, the restoration of homeostasis within the monocyte compartment in B27 BM after antibiotics ( Figure 2 ) also reversed the TNFα-dependent enhancement of osteoclast differentiation in these animals ( Figure 5 ). Thus, treatment of B27 rats with oral antibiotics not only resolves their microbiota-dependent intestinal inflammation, but also reduced the levels of circulating CCL2, restored homeostasis to blood and BM M O s, and reversed defects in osteoclasts generated from these monocytes.
Discussion
It is becoming increasing apparent that the microbial environment within the gut is relevant to not only intestinal pathologies but also rheumatic diseases (i.e., RA and AS) (14) . Overexpression of HLA-B27 and β 2 -microglobulin in rats leads to multi-systemic SpA-like inflammation that starts within the gut(1) and is associated with intestinal dysbiosis in early stages of disease development (4, 15) . These animals provide a model to examine mechanisms of microbial-mediated systemic inflammation and bone disease, which are also observed in One limitation of our study is that we were not been able to show the in vivo consequences of antibiotic treatment on bone pathology. However, it is important to note that the B27 rats used in this study were not old enough to show overt signs of bone pathology.
This includes no observable changes in circulating bone turnover markers (i.e., collagen type 1 cross-linked C-telopeptide and procollagen type 1 N-terminal propeptide), osteoclast number at bone surfaces, or bone architecture via microCT (data not shown). Studies in our laboratory have only been able to detect increased osteoclast numbers at bone surfaces and changes in bone architecture in B27 rats that are a minimum of 36 weeks old (data not
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(n=9 for B27-CTRL and n=12 for B27-ABX) and one experiment using WT rats (n=3 WT animal and total BMCs were placed in the top section of a bare filter trans-well. Increasing concentrations of recombinant rat CCL2 were used as chemo-attractant in the bottom section of the transwells. After 3 hours, trans-migrated cells were collected, stained and quantified via flow cytometry. Data were analysed with 2-way ANOVA and Dunnett's post-hoc test comparing each data set to the 0 ng/ml values. Data shown are from 1 experiment performed in triplicate. Bars show mean ± SD. *= P≤0.05; **= P≤0.01; ****= P≤0.0001. (C) Plasma was collected from B7 and B27 animals and CCL2 plasma levels quantified by ELISA. Data were analysed with Mann Whitney test. *= P≤0.05; n=6 for both B7 and B27 samples. (D) Blood from B27 animals receiving the vehicle (CTRL) was collected twice a week for 4 weeks; numbers of CD43 lo and CCL2 plasma levels were measured for each sample. Samples were collected from 2 different experiments and results pooled. Correlation analysis was performed using Pearson r test. n=50. (E) Plasma was collected at different time points (day 1 to 26) from B27 and WT rats treated with ABX or water (CTRL) and CCL2 measured by ELISA. Plasma CCL2 of 3 different experiments pooled together in B27 rats and 1 experiment using WT. Error bars shown mean ± SD. In B27-CTRL n=9; in B27-ABX n=12; in WT-CTRL n=3; in WT-ABX n=3. Data were analysed using 2-way ANOVA and Sidak's multiple comparison test for repeated measure. *=P≤0.05; **=P≤0.005; ***=P≤0.0005. (F) IL-1α was measured in day 21 plasma samples from both WT and B27 groups. Error bars indicate mean ± SD of n=9-10 for B27 and n=3 for WT groups. Kruskal-Wallis test with Dunn's multiple comparisons test was used to assess the significance. **=
